Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1581178 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $6.55Day +9.72%Mkt cap $213M1Y +23.8%Off 52W high −29.7%Vol (1Y) 61.5%
Daily closing price, split-adjusted to the current basis; 2.3y shown of 578 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest16.6% of sh out |
| Days to cover25.7d |
| 13F net flow (QoQ)+10.35% |
| Top-10 13F concentration63.6% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$38.6M |
| ROE−66.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−13.2% |
| 1Y+23.8% |
| Since incept. (ann.)+39.2% |
Total return through 2026-07-30 · series begins 2024-04-04. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)61.5% |
| Ann. volatility (3Y)64.4% |
| Sharpe (1Y)0.56 |
| Sharpe (3Y)0.84 |
| Max drawdown (1Y)−35.9% |
| Max drawdown (3Y)−35.9% |
| Beta (3Y vs SPY)1.08 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Beutel, Goodman & Co Ltd. | 3.7M | $26M | — | −1.2% |
| Affinity Asset Advisors, LLC | 1.6M | $12M | — | +429.7% |
| Balyasny Asset Management L.P. | 1.4M | $10M | — | +0.0% |
| Vivo Capital, LLC | 1.4M | $10M | — | +0.0% |
| Ikarian Capital, LLC | 1.2M | $9M | — | +99.1% |
| GREAT POINT PARTNERS LLC | 1.2M | $9M | — | +0.0% |
| SCOTIA CAPITAL INC. | 1.3M | $7M | — | +4.4% |
| Point72 Asset Management, L.P. | 967,575 | $7M | — | +35.9% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding not shown: no SEC cover-page share count falls within 120 days of the 2026-Q1 quarter end, so any percentage would rest on a count that cannot speak for this quarter. Holder share counts are shown as filed.
No reported quarters on file for EPRX.
